Ventyx Biosciences, Inc.VTYXNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank50
3Y CAGR-0.0%
5Y CAGR+69.0%
Year-over-Year Change
Research and development spending
3Y CAGR
-0.0%/yr
Annual compound
5Y CAGR
+69.0%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
13.8x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $87.69M | -25.1% |
| 2024 | $117.00M | -33.4% |
| 2023 | $175.77M | +100.3% |
| 2022 | $87.74M | +50.0% |
| 2021 | $58.48M | +818.6% |
| 2020 | $6.37M | +79.2% |
| 2019 | $3.55M | - |